ABPI MED Solutions - MESI ABPI MED
ABPI MED Solutions – MESI ABPI MED

World’s Fastest Ankle-Brachial Index Screening Device

From secondary to primary healthcare with the help of technology

MESI founders identified the need of primary healthcare for more simple and reliable diagnostic technology.

Cardiovascular diseases cause 35% of deaths globally. Efficient diagnostics is the only way to lower this number.

With early diagnosis of Peripheral Arterial Disease, the Automated Ankle-Brachial Index Measuring Device – MESI APBI MD, could help more than 200 million people.

Jakob Šušterič
CEO, co-founder

MESI ABI MD is extremely time-saving, improves productivity, as well as increases the patient’s and doctor’s satisfaction.

ANKLE-BRACHIAL INDEX MEASUREMENT Simple solution for diagnosing PAD

Ankle-Brachial-Pressure Index (ABI) is a very simple comparison of blood pressure in the arm and legs. It is non-invasive and painless. With MESI ABI MD, the procedure becomes reliable, objective and even possible to be performed as a screening device in primary healthcare. ABI screening is incredibly important for at least two reasons:

  • It is a reliable predictor of the occlusion of lower extremity arteries – PAD. Detection of PAD is even more important when we know, that over 70% of the population is not aware that they have occluded arteries.
  • Because of the high correspondence of PAD with Coronary Artery Disease (CAD) and Cerebrovascular Disease (CVD), patients diagnosed with PAD have a greater chance of early diagnosis of CAD and CVD.